Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA

The United States Food and Drug Administration (US FDA) inspected Unit-IV of APL Healthcare Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, situated at Palchur village and part of Palepalem Village Naidupeta Mandal, SPSR Nellore District, 524126, Andhra Pradesh, from December 08 to December 17, 2025. At the end of the inspection, a 'Form 483' was issued with 05 observations.

The Unit has now received an Establishment Inspection Report (EIR) classifying the facility as 'Voluntary Action Indicated' (VAI) and this inspection is now "closed".

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1304.60 as compared to the previous close of Rs. 1285.85. The total number of shares traded during the day was 40241 in over 2619 trades.

The stock hit an intraday high of Rs. 1318.00 and intraday low of 1289.00. The net turnover during the day was Rs. 52657993.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals APLHealthcare Unit4 USFDA Inspection Form483 5Observations